Search for: "F. v. F."
Results 4801 - 4820
of 57,908
Sort by Relevance
|
Sort by Date
22 Jun 2022, 6:32 am
Nelsen, 34 F. 4th 258 (May 10, 2022). [read post]
22 Jun 2022, 4:25 am
In Inter-Cooperative Exchange v. [read post]
22 Jun 2022, 4:00 am
Housen v. [read post]
22 Jun 2022, 2:52 am
Pp. 9–11. 994 F. 3d 994, reversed and remanded. [read post]
21 Jun 2022, 3:20 pm
See Eichorn v. [read post]
21 Jun 2022, 2:35 pm
” (See Lane v. [read post]
21 Jun 2022, 12:44 pm
., Inc. v. [read post]
21 Jun 2022, 11:05 am
See Eichorn v. [read post]
21 Jun 2022, 10:06 am
See Eichorn v. [read post]
21 Jun 2022, 8:35 am
[3] 400 F.3d 613 (8th Cir. 2005) [read post]
21 Jun 2022, 8:29 am
., DeHart v. [read post]
21 Jun 2022, 8:29 am
., DeHart v. [read post]
21 Jun 2022, 6:09 am
Department of Homeland Security, — F. [read post]
21 Jun 2022, 12:18 am
See, e.g., Teva, 595 F.3d at 1317-18; see also Apotex, Inc. v. [read post]
20 Jun 2022, 9:01 pm
Supreme Court ruled in Southwest Airlines Co. v. [read post]
20 Jun 2022, 6:49 am
In its June 9, 2022 decision in Spiegel v. [read post]
20 Jun 2022, 6:28 am
Read the opinion The post TIMOTHY SCHNUPP v. [read post]
20 Jun 2022, 5:57 am
Mglej v. [read post]
19 Jun 2022, 5:05 pm
In a seminal discrimination case, Casteneda v. [read post]
19 Jun 2022, 4:44 pm
The Justices of that Court, however, would probably be the first to disclaim any credibility on the causes of any disease.[3] The authors further distort the notion of signature diseases by stating that “[v]aginal adenocarcinoma in young women appears to be a signature disease associated with maternal use of DES. [read post]
